Real-time quaking-induced conversion: A highly sensitive assay for prion detection

Prion

Volumn 5, Issue 3, 2011, Pages 150-153

  Atarashi, Ryuichiro ^a   Sano, Kazunori ^a   Satoh, Katsuya ^a   Nishida, Noriyuki ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Cerebrospinal fluid; CJD; Creutzfeldt Jakob disease; CSF; Prion; Real time quaking induced conversion; RT QUIC

Indexed keywords

AMYLOID; FLUORESCENT DYE; GUANIDINE; METHIONINE; PRION PROTEIN; PROTEIN 14 3 3; THIOFLAVINE; VALINE;

ALZHEIMER DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; CEREBROSPINAL FLUID; CHRONIC WASTING DISEASE; CREUTZFELDT JAKOB DISEASE; ESCHERICHIA COLI; FATAL FAMILIAL INSOMNIA; HUMAN; NONHUMAN; NOTE; PRION DISEASE; PROTEIN DETERMINATION; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; REAL TIME QUAKING INDUCED CONVERSION; SCRAPIE; SENSITIVITY AND SPECIFICITY;

ANIMALS; BIOLOGICAL ASSAY; CATTLE; CREUTZFELDT-JAKOB SYNDROME; ENCEPHALOPATHY, BOVINE SPONGIFORM; HUMANS; PRION DISEASES; PRPC PROTEINS; SENSITIVITY AND SPECIFICITY; WASTING DISEASE, CHRONIC;

BOVINAE;

EID: 80052802802     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.5.3.16893     Document Type: Note

References (29)

1. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363-83. (Pubitemid 28525623)
2. Hamaguchi T, Noguchi-Shinohara M, Nozaki I, Nakamura Y, Sato T, Kitamoto T, et al. The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures. Neuropathology 2009; 29:625-31.
3. Ironside JW. Variant Creutzfeldt-Jakob disease. Haemophilia 5:175-80.
4. Castilla J, Saa P, Morales R, Abid K, Maundrell K, Soto C. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol 2006; 412:3-21. (Pubitemid 44548570)
5. Sc amplification technique. Protein Pept Lett 2009; 16:256-9.
6. Saa P, Castilla J, Soto C. Presymptomatic detection of prions in blood. Science 2006; 313:92-4. (Pubitemid 44051260)
7. Atarashi R, Moore RA, Sim VL, Hughson AG, Dorward DW, Onwubiko HA, et al. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods 2007; 4:645-50. (Pubitemid 47202476)
8. Colby DW, Zhang Q, Wang S, Groth D, Legname G, Riesner D, et al. Prion detection by an amyloid seeding assay. Proc Natl Acad Sci USA 2007; 104:20914-9.
9. Atarashi R, Wilham JM, Christensen L, Hughson AG, Moore RA, Johnson LM, et al. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods 2008; 5:211-2.
10. Orru CD, Wilham JM, Hughson AG, Raymond LD, McNally KL, Bossers A, et al. Human variant Creutzfeldt-Jakob disease and sheep scrapie PrP(res) detection using seeded conversion of recombinant prion protein. Protein Eng Des Sel 2009; 22:515-21.
11. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, et al. Cell-free formation of protease-resistant prion protein. Nature 1994; 370:471-4. (Pubitemid 24263553)
12. Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 2011; 17:175-8.
13. Toth SI, Smith LA, Ahmed SA. Extreme sensitivity of botulinum neurotoxin domains towards mild agitation. J Pharm Sci 2009; 98:3302-11.
14. Collins SR, Douglass A, Vale RD, Weissman JS. Mechanism of prion propagation: amyloid growth occurs by monomer addition. PLoS Biol 2004; 2:321.
15. Lansbury PT Jr, Caughey B. The chemistry of scrapie infection: implications of the 'ice 9' metaphor. Chem Biol 1995; 2:1-5.
16. Sluzky V, Tamada JA, Klibanov AM, Langer R. Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. Proc Natl Acad Sci USA 1991; 88:9377-81. (Pubitemid 21915634)
17. Treuheit MJ, Kosky AA, Brems DN. Inverse relationship of protein concentration and aggregation. Pharm Res 2002; 19:511-6. (Pubitemid 34408953)
18. Caughey B, Kocisko DA, Raymond GJ, Lansbury PT Jr. Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state. Chem Biol 1995; 2:807-17. (Pubitemid 3014704)
19. Baskakov IV, Bocharova OV. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features. Biochemistry 2005; 44:2339-48. (Pubitemid 40279538)
20. Jain S, Udgaonkar JB. Evidence for stepwise formation of amyloid fibrils by the mouse prion protein. J Mol Biol 2008; 382:1228-41.
21. Stohr J, Weinmann N, Wille H, Kaimann T, Nagel- Steger L, Birkmann E, et al. Mechanisms of prion protein assembly into amyloid. Proc Natl Acad Sci USA 2008; 105:2409-14. (Pubitemid 351520527)
22. Horiuchi M, Caughey B. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the proteaseresistant state. EMBO J 1999; 18:3193-203. (Pubitemid 29276566)
23. Sc protease resistance and conversion-inducing activity. J Biol Chem 2004; 279:40788-94.
24. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46:224-33. (Pubitemid 29382879)
25. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996; 335:924-30. (Pubitemid 26314445)
26. Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998; 43:32-40. (Pubitemid 28124646)
27. Satoh K, Tobiume M, Matsui Y, Mutsukura K, Nishida N, Shiga Y, et al. Establishment of a standard 14-3-3 protein assay of cerebrospinal fluid as a diagnostic tool for Creutzfeldt-Jakob disease. Lab Invest 2010; 90:1637-44.
28. Orru CD, Wilham JM, Raymond LD, Kuhn F, Schroeder B, Raeber AJ, et al. Prion disease blood test using immunoprecipitation and improved quaking-induced conversion. MBio 2011; 2:00078-11.
29. Wilham JM, Orru CD, Bessen RA, Atarashi R, Sano K, Race B, et al. Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog 2011; 6:1001217.